Header Logo

Connection

RACHEL SCHIFF to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications RACHEL SCHIFF has written about Dose-Response Relationship, Drug.
RACHEL SCHIFF
Connection Strength
0.047
Dose-Response Relationship, Drug
  1. Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer. Clin Cancer Res. 2021 05 01; 27(9):2648-2662.
    View in: PubMed
    Score: 0.035
  2. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol. 2006 Mar; 20(3):491-502.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.